• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Pharmaceutical Market
    Pharmaceutical News
    Pharmaceutical Stocks
    • Pharmaceutical Market
    • Pharmaceutical News
    • Pharmaceutical Stocks
    pharmaceutical investing

    Bausch Health Companies To Present Latest Products

    Bryan Mc Govern
    Apr. 29, 2019 08:51AM PST
    Pharmaceutical Investing

    Bausch + Lomb, a subsidiary of Bausch Health Companies, announced the presentation of 26 new scientific analyses and three posters at the upcoming American Society of Cataract and Refractive Surgery Annual Meeting.

    Bausch + Lomb, a subsidiary of Bausch Health Companies (NYSE:BHC,TSX:BHC), announced the presentation of 26 new scientific analyses and three posters at the upcoming American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting.

    As quoted in the press release:

    “These new scientific presentations reflect the positive experiences that ophthalmic surgeons are having with Bausch + Lomb products, including the Stellaris Elite™ vision enhancement system and enVista intraocular lenses,” said Joe Gordon, U.S. president, Bausch + Lomb. “We are pleased and proud to see so many of our customers and their patients benefiting from our technologies, and grateful for their willingness to share their data, experiences and insights with others attending the ASCRS meeting.”

    The company will also hold a number of educational events and its first in-booth #ExperienceExchange where customers will have the opportunity to join internationally recognized surgeons in a one-on-one setting to discuss best practices, learn from the experiences of their peers and get more clinical insight into Bausch + Lomb surgical technologies. These include the Stellaris Elite vision enhancement system for cataract and retina surgery, the VICTUS femtosecond laser for advanced cataract and corneal applications, and its broad selection of intraocular lenses (IOLs) and delivery systems, including the enVista MX60E with StableFlex technology and the enVista toric MX60T.

    Click here to read the full press release.

    pharmaceutical investing
    The Conversation (0)

    Go Deeper

    AI Powered
    Senior woman doing exercises alongside closeup of DNA.

    5 US Longevity and Anti-aging Stocks to Watch in 2025

    Stethoscope connected to a phone with medical data overlay.

    Top 5 Small-cap Medical Device Stocks (Updated January 2025)

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Pharmaceutical Investing Stocks

    Invion Limited

    IVX:AU

    Cardiol Therapeutics

    CRDL:CA
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×